Pharmaceutical Sources

Latest News for: Pharmaceutical sources

Edit

HIV Therapeutics Market 2019-2023 | Growing Awareness About HIV and Increasing Number of Initiatives to ...

The Oneida Daily Dispatch 15 Feb 2020

LONDON--(BUSINESS WIRE)--Feb 14, 2020-- ... This press release features multimedia ... - Advertisement - ... Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources ... and Teva Pharmaceutical Industries Ltd ... View source version on businesswire.com. ... BIOTECHNOLOGY PHARMACEUTICAL HEALTH. SOURCE....

Edit

Updated CheckMate -025 Results Show 26% of Patients Treated with Opdivo are Alive at Five ...

The Marshall News Messenger 15 Feb 2020

We source innovation internally, and in collaboration with academia, government, advocacy groups and biotechnology companies, to help make the promise of transformational medicines, like I-O, a reality for patients ... About the Bristol-Myers Squibb and Ono Pharmaceutical Collaboration ... View source version on businesswire.com. ... SOURCE....

Edit

Opdivo (nivolumab) Plus Yervoy (ipilimumab) Demonstrates Continued Survival Benefit at 42-Month Follow-up in Patients with ...

The Marshall News Messenger 15 Feb 2020

Edit

Interactive 3 Day Programme on Drafting Commercial Contracts in the Pharmaceutical Industry (London, United Kingdom ...

Ellensburg Daily Record 14 Feb 2020

The "Drafting Commercial Contracts for the Pharmaceutical Industry" conference has been added to ResearchAndMarkets.com's offering ... The presenters will use a mixture of practical exercises and cases from the pharmaceutical industry to ensure you leave the seminar with the knowledge and skills to perfect all stages of the process ... SOURCE....

Edit

Hot Topics Recap: Coronavirus

The Marshall News Messenger 14 Feb 2020

NEW YORK-- Source ... MILTON KEYNES, England-- Source ... BURLINGTON, Mass.-- Source ... GENEVA, Ill.-- Source ... NEW YORK-- Source ... SALT LAKE CITY-- Source ... TAIPEI, Taiwan-- Source ... HONG KONG-- SOURCE ... CHAPEL HILL, N.C.-- Source ... LONDON-- Source ... PAUL, Minn.-- Source ... OLDWICK, N.J.-- Source ... OXFORD, England-- Source ... TAIPEI, Taiwan-- Source ... LOS ANGELES-- Source ... SOURCE....

Edit

Proteinuria Therapeutics Market 2019-2023 | Increasing Prevalence of Associated Risk Factors to Boost Growth | Technavio

The Record 14 Feb 2020

View the full release here ... Scope. Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources ... Inc., Novartis AG, Pfizer Inc., Sanofi, Takeda Pharmaceutical Co ... and Teva Pharmaceutical Industries Ltd ... View source version on businesswire.com. ... BIOTECHNOLOGY PHARMACEUTICAL HEALTH. SOURCE....

Edit

Dilated Cardiomyopathy - Pipeline Review, H1 2020 | Key Players Include Berlin Cures Holding AG, ...

The Marshall News Messenger 14 Feb 2020

The guide is built using data and information sourced from a proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources ... View source version on businesswire.com. ... SOURCE....

Edit

Deciphera Pharmaceuticals Announces Pricing of Public Offering of Common Stock

The Marshall News Messenger 14 Feb 2020

Deciphera Pharmaceuticals, Inc ... About Deciphera Pharmaceuticals. Deciphera Pharmaceuticals is a clinical-stage biopharmaceutical company focused on improving the lives of cancer patients by tackling key mechanisms of drug resistance that limit the rate and/or durability of response to existing cancer therapies ... Deciphera Pharmaceuticals, Inc ... SOURCE....

Edit

The global carotenoids market size is projected to grow from USD 1.5 billion in 2019 ...

The Salamanca Press 14 Feb 2020

Key factors encouraging the growth of the carotenoids market include the increasing demand in the pharmaceutical industry, particularly for naturally sourced carotenoids, and opportunities to expand in the high-growth potential markets ... The pharmaceutical sector is also witnessing ......

Edit

InMed Pharmaceuticals Reports Second Quarter Fiscal 2020 Financial Results and Provides R&D and Business Update

The Record 14 Feb 2020

14, 2020 /PRNewswire/ - InMed Pharmaceuticals Inc ... "Since then, we revealed cannabinol (CBN) as the active pharmaceutical ingredient in both of our lead programs, beginning with INM-755 for the potential treatment of epidermolysis bullosa, followed by INM-088 for the potential treatment of glaucoma ... SOURCE InMed Pharmaceuticals Inc....

Edit

InMed Pharmaceuticals Inc. (IMLFF) Reports Second Quarter Fiscal 2020 Financial Results

MarijuanaStocks 14 Feb 2020

InMed Pharmaceuticals Reports Second Quarter Fiscal 2020 Financial Results and Provides R&D and Business Update. InMed Pharmaceuticals Inc ... InMed Pharmaceuticals Inc.� ... InMed Pharmaceuticals Inc ... InMed Pharmaceuticals Inc ... InMed Pharmaceuticals is ... SOURCE InMed Pharmaceuticals Inc....

Edit

LuPIN Trial Interim Results Indicate Striking Survival Benefit

The Marshall News Messenger 14 Feb 2020

SYDNEY--(BUSINESS WIRE)--Feb 14, 2020--. (ASX. NOX) is pleased to announce positive interim results from its LuPIN Phase 1/2 clinical trial ... Vincent’s Hospital Sydney ... “The study investigators at St ... (ASX.NYR) ... View source version on businesswire.com. ... RESEARCH HOSPITALS GENETICS CLINICAL TRIALS BIOTECHNOLOGY HEALTH PHARMACEUTICAL SCIENCE ONCOLOGY. SOURCE....

Edit

IMV Announces Board Retirement

The Marshall News Messenger 14 Feb 2020

DARTMOUTH, Nova Scotia--(BUSINESS WIRE)--Feb 14, 2020--. IMV Inc. (Nasdaq ... Mr ... “It has been a source of humility to work with so many talented scientists and committed shareholders for so many years,” Mr ... View source version on businesswire.com. ... O ... SCIENCE BIOTECHNOLOGY RESEARCH PHARMACEUTICAL HUMAN RESOURCES ONCOLOGY HEALTH PROFESSIONAL SERVICES. SOURCE....